News & Articles
Tag: Dr. Marwan Sabbagh
Scientists, Clinicians Brainstorm Future of C9orf72 ALS, FTD Research
A recent summit hosted by Barrow Neurological Institute united scientists and clinicians nationally and internationally with a shared goal: to improve the lives of people with C9orf72-associated ALS...
Awards & Recognitions — May 2023
Vice Chair of Research Marwan Sabbagh, MD, a behavioral neurologist in the Alzheimer’s and Memory Disorders Program at Barrow, has been named the inaugural Vice Chair of Research...
Barrow Neurologist Discusses Alzheimer’s Drug Trial Results
A study published in the New England Journal of Medicine found that an experimental Alzheimer’s drug, known as lecanemab, moderately slowed the progression of the disease. However, the...
Barrow Neurologist Weighs in on Alzheimer’s Drug
Aducanumab, marketed under the brand name Aduhelm, is the first new Alzheimer’s treatment to be approved by the U.S. Food and Drug Administration in 18 years. It is...